Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001570562-21-000073
Filing Date
2021-03-01
Accepted
2021-03-01 18:47:02
Documents
1
Period of Report
2021-02-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_161464240247049.html 4  
1 FORM 4 wf-form4_161464240247049.xml 4 4190
  Complete submission text file 0001570562-21-000073.txt   5595
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Issuer) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address
Muilenburg Crystal (Reporting) CIK: 0001848477 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38381 | Film No.: 21700358